EVIDENCE OF THE BENEFITS OF COGNITIVE BEHAVIORAL THERAPY ASSOCIATED WITH THE PHARMACOLOGICAL TREATMENT OF SCHIZOPHRENIA: SYSTEMATIC REVIEW

Detalhes bibliográficos
Autor(a) principal: Wanderley, Dierlen Lourrainy Souza
Data de Publicação: 2021
Outros Autores: Nogueira, Kamila Menara de Oliveira, Mattos, Mússio Pirajá, Gomes, Daiene Rosa
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Baiana de Saúde Pública (Online)
Texto Completo: https://rbsp.sesab.ba.gov.br/index.php/rbsp/article/view/3108
Resumo: Psychotherapy associated with pharmacological treatment shows advances in the treatment of schizophrenia. In this sense, this study shows the results of national and international studies that evaluated the benefits of Cognitive Behavioral Therapy in the pharmacological treatment of schizophrenia. This is a systematic review of articles indexed in the PubMed and ScienceDirect databases, published between January 2000 and September 2016, based on the health descriptors: “cognitive behavioral therapy” AND “schizophrenia” AND “antipsychotics”. Methodological quality was assessed using the Effective Public Health Practice Project: Quality Assessment Tool for Quantitative Studies scale. In total, 11 articles were included in the review. The association among therapies allowed to identify better adherence to pharmacological treatment, decrease in initial symptoms (positive, negative and general psychopathology), decrease in the rate of treatment interruption, lower risk of relapse, relapses and readmission, improvement in social interaction, occupational and quality of life. The drug treatment is not sufficiently complete to act on all the characteristic symptoms of the disease, and the association with CBT has been shown to be effective, becoming an important care instrument in the care of schizophrenia.
id IBICT-3_c0eb3d7679c87962d21c3a3af8a36b45
oai_identifier_str oai:ojs.pkp.sfu.ca:article/3108
network_acronym_str IBICT-3
network_name_str Revista Baiana de Saúde Pública (Online)
repository_id_str
spelling EVIDENCE OF THE BENEFITS OF COGNITIVE BEHAVIORAL THERAPY ASSOCIATED WITH THE PHARMACOLOGICAL TREATMENT OF SCHIZOPHRENIA: SYSTEMATIC REVIEWEVIDENCIA DE LOS BENEFICIOS DE LA TERAPIA COGNITIVO-CONDUCTUAL ASOCIADA AL TRATAMIENTO FARMACOLÓGICO DE LA ESQUIZOFRENIA: REVISIÓN SISTEMÁTICAEVIDÊNCIAS DOS BENEFÍCIOS DA TERAPIA COGNITIVO-COMPORTAMENTAL ASSOCIADA AO TRATAMENTO FARMACOLÓGICO DA ESQUIZOFRENIA: REVISÃO SISTEMÁTICAPsicoterapiaTerapia cognitivo-comportamentalEsquizofreniaFarmacoterapiaRevisão sistemáticaPsicoterapiaTerapia cognitivo-conductualEsquizofreniaFarmacoterapiaRevisión sistemáticaPsychotherapyCognitive behavioral therapySchizophreniaDrug therapySystematic reviewPsychotherapy associated with pharmacological treatment shows advances in the treatment of schizophrenia. In this sense, this study shows the results of national and international studies that evaluated the benefits of Cognitive Behavioral Therapy in the pharmacological treatment of schizophrenia. This is a systematic review of articles indexed in the PubMed and ScienceDirect databases, published between January 2000 and September 2016, based on the health descriptors: “cognitive behavioral therapy” AND “schizophrenia” AND “antipsychotics”. Methodological quality was assessed using the Effective Public Health Practice Project: Quality Assessment Tool for Quantitative Studies scale. In total, 11 articles were included in the review. The association among therapies allowed to identify better adherence to pharmacological treatment, decrease in initial symptoms (positive, negative and general psychopathology), decrease in the rate of treatment interruption, lower risk of relapse, relapses and readmission, improvement in social interaction, occupational and quality of life. The drug treatment is not sufficiently complete to act on all the characteristic symptoms of the disease, and the association with CBT has been shown to be effective, becoming an important care instrument in the care of schizophrenia.La psicoterapia asociada al tratamiento farmacológico presenta avances en el tratamiento de la esquizofrenia. En este sentido, el presente estudio tiene como objetivo resumir los resultados de estudios nacionales e internacionales que evaluaron los beneficios de la terapia cognitivo-conductual (TCC) en el tratamiento farmacológico de la esquizofrenia. Esta es una revisión sistemática de artículos indexados en las bases de datos PubMed y ScienceDirect, publicados entre enero 2000 y septiembre de 2016, utilizando los descriptores de salud: “cognitive behavioral therapy” AND “schizophrenia” AND “antipsychotics”. La calidad metodológica se evaluó mediante la escala Effective Public Health Practice Project: Quality Assessment Tool for Quantitative Studies. Se incluyeron 11 artículos en la revisión. La asociación entre las terapias permitió identificar una mejor adherencia al tratamiento farmacológico, disminución de los síntomas iniciales (positivos, negativos y psicopatología general), disminución de la tasa de interrupción del tratamiento, menor riesgo de recaída y reingreso, así como mejora en la interacción social, ocupacional y calidad de vida. Se concluye que el tratamiento farmacológico no es lo suficientemente completo como para actuar sobre todos los síntomas característicos de la enfermedad, y se ha demostrado que la asociación con la TCC es efectiva, convirtiéndose en un importante instrumento de atención en la esquizofrenia.A psicoterapia associada ao tratamento farmacológico apresenta avanços no tratamento da esquizofrenia. Nesse sentido, o presente trabalho tem o objetivo de sumarizar os resultados de estudos nacionais e internacionais que avaliaram os benefícios da Terapia Cognitivo-Comportamental (TCC) associados ao tratamento farmacológico da esquizofrenia. Trata-se de uma revisão sistemática de artigos indexados nas bases de dados PubMed e ScienceDirect, publicados entre janeiro de 2000 e setembro de 2016, localizados a partir dos descritores em saúde: “cognitive behavioral therapy” AND “schizophrenia” AND “antipsychotics”. A qualidade metodológica foi avaliada por meio da escala Effective Public Health Practice Project: Quality Assessment Tool for Quantitative Studies. Foram incluídos 11 artigos na revisão. A associação entre as terapias permitiu identificar melhor adesão ao tratamento farmacológico, diminuição dos sintomas iniciais (positivos, negativos e psicopatologia geral), diminuição da taxa de interrupção de tratamento, menor risco de recaída, recidivas e readmissão, bem como melhora na interação social, ocupacional e na qualidade de vida. Conclui-se que o tratamento medicamentoso não é suficientemente completo para agir em todos os sintomas característicos da doença, e a associação com a TCC tem se mostrado eficaz, se configurando como um importante instrumento de cuidado na esquizofrenia.SESAB2021-02-25info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rbsp.sesab.ba.gov.br/index.php/rbsp/article/view/310810.22278/2318-2660.2019.v43.n3.a3108Revista Baiana de Saúde Pública; v. 43 n. 3 (2019); 666-6842318-26600100-023310.22278/2318-2660.2019.v43.N3reponame:Revista Baiana de Saúde Pública (Online)instname:Secretaria da Saúde do Estado da Bahia (Sesab)instacron:IBICTporhttps://rbsp.sesab.ba.gov.br/index.php/rbsp/article/view/3108/2805Copyright (c) 2019 Revista Baiana de Saúde Públicainfo:eu-repo/semantics/openAccessWanderley, Dierlen Lourrainy SouzaNogueira, Kamila Menara de OliveiraMattos, Mússio PirajáGomes, Daiene Rosa2023-02-13T19:23:52Zoai:ojs.pkp.sfu.ca:article/3108Revistahttps://rbsp.sesab.ba.gov.br/index.php/rbspPUBhttps://rbsp.sesab.ba.gov.br/index.php/rbsp/oai||saude.revista@saude.ba.gov.br|| rbsp.saude@saude.ba.gov.br2318-26600100-0233opendoar:2024-03-06T12:58:07.807508Revista Baiana de Saúde Pública (Online) - Secretaria da Saúde do Estado da Bahia (Sesab)false
dc.title.none.fl_str_mv EVIDENCE OF THE BENEFITS OF COGNITIVE BEHAVIORAL THERAPY ASSOCIATED WITH THE PHARMACOLOGICAL TREATMENT OF SCHIZOPHRENIA: SYSTEMATIC REVIEW
EVIDENCIA DE LOS BENEFICIOS DE LA TERAPIA COGNITIVO-CONDUCTUAL ASOCIADA AL TRATAMIENTO FARMACOLÓGICO DE LA ESQUIZOFRENIA: REVISIÓN SISTEMÁTICA
EVIDÊNCIAS DOS BENEFÍCIOS DA TERAPIA COGNITIVO-COMPORTAMENTAL ASSOCIADA AO TRATAMENTO FARMACOLÓGICO DA ESQUIZOFRENIA: REVISÃO SISTEMÁTICA
title EVIDENCE OF THE BENEFITS OF COGNITIVE BEHAVIORAL THERAPY ASSOCIATED WITH THE PHARMACOLOGICAL TREATMENT OF SCHIZOPHRENIA: SYSTEMATIC REVIEW
spellingShingle EVIDENCE OF THE BENEFITS OF COGNITIVE BEHAVIORAL THERAPY ASSOCIATED WITH THE PHARMACOLOGICAL TREATMENT OF SCHIZOPHRENIA: SYSTEMATIC REVIEW
Wanderley, Dierlen Lourrainy Souza
Psicoterapia
Terapia cognitivo-comportamental
Esquizofrenia
Farmacoterapia
Revisão sistemática
Psicoterapia
Terapia cognitivo-conductual
Esquizofrenia
Farmacoterapia
Revisión sistemática
Psychotherapy
Cognitive behavioral therapy
Schizophrenia
Drug therapy
Systematic review
title_short EVIDENCE OF THE BENEFITS OF COGNITIVE BEHAVIORAL THERAPY ASSOCIATED WITH THE PHARMACOLOGICAL TREATMENT OF SCHIZOPHRENIA: SYSTEMATIC REVIEW
title_full EVIDENCE OF THE BENEFITS OF COGNITIVE BEHAVIORAL THERAPY ASSOCIATED WITH THE PHARMACOLOGICAL TREATMENT OF SCHIZOPHRENIA: SYSTEMATIC REVIEW
title_fullStr EVIDENCE OF THE BENEFITS OF COGNITIVE BEHAVIORAL THERAPY ASSOCIATED WITH THE PHARMACOLOGICAL TREATMENT OF SCHIZOPHRENIA: SYSTEMATIC REVIEW
title_full_unstemmed EVIDENCE OF THE BENEFITS OF COGNITIVE BEHAVIORAL THERAPY ASSOCIATED WITH THE PHARMACOLOGICAL TREATMENT OF SCHIZOPHRENIA: SYSTEMATIC REVIEW
title_sort EVIDENCE OF THE BENEFITS OF COGNITIVE BEHAVIORAL THERAPY ASSOCIATED WITH THE PHARMACOLOGICAL TREATMENT OF SCHIZOPHRENIA: SYSTEMATIC REVIEW
author Wanderley, Dierlen Lourrainy Souza
author_facet Wanderley, Dierlen Lourrainy Souza
Nogueira, Kamila Menara de Oliveira
Mattos, Mússio Pirajá
Gomes, Daiene Rosa
author_role author
author2 Nogueira, Kamila Menara de Oliveira
Mattos, Mússio Pirajá
Gomes, Daiene Rosa
author2_role author
author
author
dc.contributor.author.fl_str_mv Wanderley, Dierlen Lourrainy Souza
Nogueira, Kamila Menara de Oliveira
Mattos, Mússio Pirajá
Gomes, Daiene Rosa
dc.subject.por.fl_str_mv Psicoterapia
Terapia cognitivo-comportamental
Esquizofrenia
Farmacoterapia
Revisão sistemática
Psicoterapia
Terapia cognitivo-conductual
Esquizofrenia
Farmacoterapia
Revisión sistemática
Psychotherapy
Cognitive behavioral therapy
Schizophrenia
Drug therapy
Systematic review
topic Psicoterapia
Terapia cognitivo-comportamental
Esquizofrenia
Farmacoterapia
Revisão sistemática
Psicoterapia
Terapia cognitivo-conductual
Esquizofrenia
Farmacoterapia
Revisión sistemática
Psychotherapy
Cognitive behavioral therapy
Schizophrenia
Drug therapy
Systematic review
description Psychotherapy associated with pharmacological treatment shows advances in the treatment of schizophrenia. In this sense, this study shows the results of national and international studies that evaluated the benefits of Cognitive Behavioral Therapy in the pharmacological treatment of schizophrenia. This is a systematic review of articles indexed in the PubMed and ScienceDirect databases, published between January 2000 and September 2016, based on the health descriptors: “cognitive behavioral therapy” AND “schizophrenia” AND “antipsychotics”. Methodological quality was assessed using the Effective Public Health Practice Project: Quality Assessment Tool for Quantitative Studies scale. In total, 11 articles were included in the review. The association among therapies allowed to identify better adherence to pharmacological treatment, decrease in initial symptoms (positive, negative and general psychopathology), decrease in the rate of treatment interruption, lower risk of relapse, relapses and readmission, improvement in social interaction, occupational and quality of life. The drug treatment is not sufficiently complete to act on all the characteristic symptoms of the disease, and the association with CBT has been shown to be effective, becoming an important care instrument in the care of schizophrenia.
publishDate 2021
dc.date.none.fl_str_mv 2021-02-25
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbsp.sesab.ba.gov.br/index.php/rbsp/article/view/3108
10.22278/2318-2660.2019.v43.n3.a3108
url https://rbsp.sesab.ba.gov.br/index.php/rbsp/article/view/3108
identifier_str_mv 10.22278/2318-2660.2019.v43.n3.a3108
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rbsp.sesab.ba.gov.br/index.php/rbsp/article/view/3108/2805
dc.rights.driver.fl_str_mv Copyright (c) 2019 Revista Baiana de Saúde Pública
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Revista Baiana de Saúde Pública
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv SESAB
publisher.none.fl_str_mv SESAB
dc.source.none.fl_str_mv Revista Baiana de Saúde Pública; v. 43 n. 3 (2019); 666-684
2318-2660
0100-0233
10.22278/2318-2660.2019.v43.N3
reponame:Revista Baiana de Saúde Pública (Online)
instname:Secretaria da Saúde do Estado da Bahia (Sesab)
instacron:IBICT
instname_str Secretaria da Saúde do Estado da Bahia (Sesab)
instacron_str IBICT
institution IBICT
reponame_str Revista Baiana de Saúde Pública (Online)
collection Revista Baiana de Saúde Pública (Online)
repository.name.fl_str_mv Revista Baiana de Saúde Pública (Online) - Secretaria da Saúde do Estado da Bahia (Sesab)
repository.mail.fl_str_mv ||saude.revista@saude.ba.gov.br|| rbsp.saude@saude.ba.gov.br
_version_ 1798948056817729536

Registros relacionados